Pilot-trial results of INF+pioglitazone

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Pilot-trial results of INF+pioglitazone

Postby Frank » Wed Jun 03, 2009 1:00 pm

A small study found a significant effectivenes of pioglitazone (an approved diabetes typ-II drug) in protecting grey matter and a positive trend towards lower lesion load:


Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
Family Elder
Posts: 543
Joined: Wed Jan 03, 2007 3:00 pm
Location: Germany


Postby dignan » Wed Jun 03, 2009 2:13 pm

Thanks for posting the abstract Frank. As I mentioned in the pipeline thread, I'm still not putting this back on the list as I'm not convinced they are going to get the funding to do another trial with this. I hope to be proved spectacularly wrong, and soon.
User avatar
Family Elder
Posts: 1608
Joined: Wed Aug 11, 2004 2:00 pm

Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service